PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan, leveraging deep expertise and proven scientific principles to deliver new biologics in hematology, oncology, and immunology. Founded in 2003, PharmaEssentia is now expanding its global presence with operations in the U.S., Japan, China and Korea.
Looking for a particular PharmaEssentia employee's phone or email?
The PharmaEssentia annual revenue was $215.4 million in 2026.
Lih-Ling Lin is the Chief Scientific Officer of PharmaEssentia.
310 people are employed at PharmaEssentia.
PharmaEssentia is based in Burlington, Massachusetts.
The NAICS codes for PharmaEssentia are [32, 325, 32541, 3254].
The SIC codes for PharmaEssentia are [283, 28].